Tag Archive for Teva Pharmaceutical

Israeli Pharmaceutical donates 10 million tablets to US hospitals

The Israeli Drugmaker, Teva Pharmaceutical rushes to send its Malaria drug to Covid-19 patients in U.S. hospitals following encouraging results from China and France. Teva said 6 million tablets will be delivered to U.S. hospitals by March 31, and more than 10 million in a month.

By Riley Griffin


Teva Pharmaceutical Industries Ltd. said it plans to donate more than 10 million tablets of hydroxychloroquine sulfate, a malaria drug touted by President Donald Trump as a potential treatment for the coronavirus, to help U.S. hospitals meet a potential surge in demand.

The Israeli company is one of the world’s largest makers of hydroxychloroquine, a less-toxic version of chloroquine, which is used in malaria, rheumatoid arthritis and lupus. Continue Reading »

Despite systemic political bias, UN continues to buy more from Israel

Since 2015 UN agencies continue to increase their purchase of Israeli innovations & services, acquiring communications & logistics services, medical & water desalination technologies and security & defense technologies for UN peacekeeping forces.

By Ariel Kahana


Despite the United Nations’ continued hostility toward Israel, the organization is increasingly choosing to purchase Israeli goods and services, according to data compiled by the Permanent Mission of Israel to the UN.

The figures show that in the past four years, various UN agencies acquired $256 million worth of Israeli goods and services, and that every year for the last four years the amount purchased has increased. Continue Reading »

Warren Buffett props up Israel’s Teva Pharmaceutical with $350 million stake

Before Buffet’s investment in Teva, the billionaire’s first non-American acquisition was of the Israeli company Iscar in 2006 for over $6B, then Ray-Q Interconnect and AgroLogic, but in 2017 the chairman and CEO of Berkshire Hathaway invested $5m. in Israel government bonds for his own personal portfolio.
 – “I’m a big believer in Israel’s economy… I didn’t invest the money in any other country. That’s the strongest vote of confidence I can give,” admitted Buffet.



With a track record for placing winning bets at opportune moments, American billionaire Warren Buffett is one of the most scrutinized investors in the world – and recent Israeli investments are showcasing his love affair with the Jewish state. Continue Reading »

Israel’s top generic drugmaker buys rival in $40 billion acquisition


The $40-billion acquisition, the largest in Israel’s history, gives Teva Pharmaceutical a large market lead and catapults it into the top 10 pharmaceutical firms globally.

By Arutz Sheva Staff


Teva Pharmaceutical on Tuesday completed its $40 billion acquisition of the generics arm of rival Allergan, a move the Israeli firm hailed as confirmation of its intention to become one of the world’s largest drugmakers.

“Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan’s generics business (Actavis Generics)” the Israeli company said in a statement.

The $40-billion deal, the largest in Israeli history, was agreed last year but finally confirmed Tuesday. Continue Reading »

Canadian delegation of 100 strong on visit to Israel


Ontario Premier Kathleen Wynne, ushering a group of over 100 Canadian politicians & business leaders, arrive in Israel to further expand on Canada-Israel cooperation.

By Gilad Morag


The Premier of the Canadian province of Ontario, Kathleen Wynne, arrived in Israel at the head of a delegation of over 100 Canadian politicians and business leaders on Sunday.

Ontario Premier Kathleen Wynne – Photo: Government of Ontario

Included in the delegation is Ontario Minister of Health and Long-Term Care Hon. Dr. Eric Hoskins, and Ontario Minister of and Development Reza Moridi, amongst others.

Ontario is the most populous province in Canada, and is also home to Toronto, the most populous city in Canada. Continue Reading »

Business: Israeli life science firms trying hard to become another Teva

Many Israeli concerns have been unsuccessful achieving the success that Teva has accomplished, because of the challenge in breaking into the innovation sector, the inability to raise proper funding for expansion, and the lack of experience in taking drugs through the regulatory process & to market.

By Reuters


As Israel’s biggest company Teva strives to get even bigger by swallowing up rival Mylan for more than $40 billion, further down the food chain a raft of upstart life science firms are struggling to climb onto the global ladder.

Photo: EPA

Now the government is starting to take notice, urged on by influential advocates, including Teva Pharmaceutical Industries’ own boss, who says the country’s economic future depends on replicating his company’s success. Continue Reading »

US Supreme Court tells Federal Circuit Court: Rethink Teva decision

Supreme Court rules for Israel’s Teva generic drug manufacturer over multiple sclerosis drug patent.


WASHINGTON – The US Supreme Court on Tuesday ruled for Teva Pharmaceutical Industries Ltd in its fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug, by sending the case back to a lower court for further review.

Israel’s Teva’s factory in Hungary – Photo: Bloomberg

On a 7-2 vote, the justices said that the US Court of Appeals for the Federal Circuit had not used the correct approach in analyzing whether the patent in question, due to expire in September 2015, was valid. Continue Reading »

City of Chicago suing Israel’s Teva Pharmaceutical over Opium


Bloomberg reported Teva being sued along with group of pharmaceutical manufacturers for allowing Chicago’s residents to become hooked on painkillers to boost their profits.

By Ynetnews


Israel’s Teva is being sued by the city of Chicago together with other major pharmaceutical manufacturers for excessively promoting painkillers, effectively getting people hooked and costing the city untold amounts of money, Bloomberg reported Tuesday.

Israeli pharma giant,Teva Pharmaceuticals – Photo: Facebook

The third largest city in the US is demanding retribution from Teva and other companies like Johnson & Johnson for the costs of dealing with almost half a million claims for opioid prescriptions. Continue Reading »

U.S. strikes Israel from patent blacklist

American drug manufactures no longer worry over Teva Pharmaceutical Industries ability to operate without legislative parameters since the Knesset passed patent changes in 2011.



Israel has been removed from a U.S. government blacklist of countries that allegedly condone the violation of intellectual property rights, Washington announced over the weekend.

teva  lab technician

A Teva lab technician. Intellectual property rights are important for Israeli R&D, too. – Photo: Ofer Vaknin

Israel had been on the list for years, in part due to pressure from U.S. drug manufacturers contending that Israeli legislation let Teva Pharmaceutical Industries violate patents. Teva is the world’s largest maker of generic drugs.

Continue Reading »

Israel business news: Teva stock jumps after U.S. Federal Court’s vindication


U.S. Federal judge acquits the Israeli pharmaceutical concern, Teva of infringing on 5 patents of the painkiller, OxyContin.

Teva shares shot up 6.7% in one day gain.

By Reuters



A federal judge said Teva Pharmaceutical Industries Ltd did not infringe five patents related to the painkiller OxyContin, helping push shares of the world’s largest generic drug manufacturer up 6.7 percent on Tuesday.


Teva’s factory in Hungary. – Photo: Bloomberg

Earlier in the day, Teva executives said at a JPMorgan healthcare conference that they were confident a new version of its multiple sclerosis drug Copaxone that requires less frequent dosing will soon win regulatory approval for use in the United States. Continue Reading »

In Stiff competition: Teva will sell Generic Viagra-impotence drug from 2017

The sales of Teva’s Generic Viagra could provide the company with succor from the specter of generic competition to its Copaxone.

By Reuters and  


Teva Pharmaceutical Industries may sell a generic form of Viagra starting in late 2017, Pfizer said on Tuesday. The announcement marks the end of protracted patent litigation between the two drugmakers.


Teva’s plant in Jerusalem. – Photo: Bloomberg

Pfizer’s U.S. patent on Viagra only lapses in 2020, including a six-month extension granted for having tested the medicine in young patients. But now, following its agreement with Pfizer, the Israeli drugmaker may launch its copycat version of the impotence drug years before other generic drugmakers.

Continue Reading »